Skip to main content

Table 1 Laboratory investigation findings of the presented case with acute myopathy following SARS-CoV2 infection

From: Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature

Investigations (normal value and unit of measurement)

Patient value on admission and range during hospital stay

Hemoglobin (13.5-17.5 g/dl)

14.5 (14.5-9.2)

Total leukocyte count (4500 to 11,000/μl)

21,100 (10,170-31,780)

 Polymorph (40-65%)

93% (62-94)

 Lymphocyte (30-50%)

4% (4-36)

Total platelet count (150,000 to 400,000/μl)

295,000 (270,000 to 480,000/μl)

C-reactive protein (< 5 mg/L)

300 (2.7-300)

Serum procalcitonin (0.10-0.49 ng/mL)

5.69 (0.27-5.69)

Serum ferritin (< 250 ng/mL)

811 (799-2185)

Serum d-dimer (< 0.4 mcg/mL)

1.25 (1.25-5.55)

Serum PT (11-13.5 s)

13 (13-15)

Serum aPTT (25-35 s)

33 (30-33)

Serum CPK (< 120 mcg/mL)

850 (637-1325)

Serum electrolytes

 

 Na+ (135-145) mmol/L

138 (134-152)

 K+ (3.5-5.5) mmol/L

4.6 (3.5-5.1)

 Ca+ (8.5-10.5) mg/dl

8.6 (7.6-8.6)

 Mg+(1.5-2.5) mmol/L

1.9 (1.9-3)

Serum creatinine (60-110 μmol/L)

87 (71-155)

Serum SGPT (7-56 U/L)

32 (32-45)

Serum troponin-I (< 0.04 ng/ml)

0.02 (0.02-0.2)

Serum Pro-BNP (< 125 pg/mL)

130 (109-130)

Serum anti GM1 antibody

(− ve)

Cerebrospinal fluid (CSF)

 

 Total protein (up to 45 mg/dl)

10

 Total WBC count (0-5/cmm)

05

  1. PT prothrombin time, aPTT activated partial thromboplastin time, CPK creatinine phosphokinase, SGPT serum glutamic pyruvic transaminase, BNP brain natriuretic peptide, WBC white blood cells